RxDoctor Payments Data

Sandra Dejong

Nurse Practitioner · Richland, MINPI 1447360433

Payments from drug & device makers

$592in general payments, 2019–2025

Across 27 payments — averaging $21.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$105
  • AstraZeneca$99
  • AbbVie$84
  • Lilly USA, LLC$61
  • Merck$50
  • Boehringer Ingelheim$42
  • plus $151 from 6 others

What the payments were for

  • Food & beverage$592100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$592 in reported general payments places this provider in the 75th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$29,796
Medicare patients
152
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin126$103,033
OzempicSemaglutide86$102,299
MounjaroTirzepatide84$90,116
TrulicityDulaglutide68$89,242
EliquisApixaban63$56,879
JanuviaSitagliptin Phosphate37$41,961
RybelsusSemaglutide21$29,230
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$24,598
FarxigaDapagliflozin Propanediol29$21,940
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$12,584
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$9,983
Omeprazole393$7,421
PremarinEstrogens, Conjugated14$7,397
Atorvastatin Calcium479$7,093
Levothyroxine Sodium644$7,061

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$61$179,358152 claims
Novo NordiskOzempic, Rybelsus$105$131,528107 claims
Boehringer IngelheimJardiance$42$103,033126 claims
PfizerEliquis, Premarin$33$64,27677 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$14$42,65463 claims
MerckJanuvia$50$41,96137 claims
AstraZenecaFarxiga$99$21,94029 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Richland

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →